Dengue fever, caused by a flavivirus named DENV, is a major global health challenge, risking almost half of the world's population. Since the early 20th century, the scientific community has faced ...

Takeda’s dengue fever vaccine Qdenga has demonstrated its long-term benefits against infection and hospitalisation in a Phase III trial. During the TIDES study (NCT02747927), two doses of the live, ...

The first-ever vaccine against dengue fever, which affects up to 400 million people per year, will be publicly available for the first time after being cleared for use in Mexico, French manufacturer ...

The world's first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries affected by the disease, following 16 years of research contributions by ...

Dengue fever caused by a flavivirus named DENV is a major global health challenge, risking almost half of the world's population. Since the early 20 th century, the scientific community has faced ...

“Dengue can affect anyone living in or traveling to endemic areas - regardless of age, health and socio-economic circumstances,” said Gary Dubin, president of Takeda’s Vaccine Business Unit.

Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests that the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is ...

Consultant Paediatrician and Founder Clinical Head of the Centre for Clinical Management of Dengue & Dengue Haemorrhagic Fever in Negombo, Dr. Lakkumar Fernando, said an internationally approved ...

The first vaccine formulated to combat dengue fever, a virus spread by the same mosquito responsible for Zika, has launched in the Philippines, according to a CNN report. Dengue fever infects nearly ...

A major outbreak of dengue fever threatens to overwhelm hospitals in Bangladesh, where an explosive measles epidemic has ...